SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-005157
Filing Date
2024-02-07
Accepted
2024-02-06 17:32:15
Documents
24
Period of Report
2024-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 63021
2 ex4-1.htm EX-4.1 130368
3 ex4-2.htm EX-4.2 122672
4 ex4-3.htm EX-4.3 126836
5 ex4-4.htm EX-4.4 126890
6 ex10-1.htm EX-10.1 253890
7 ex99-1.htm EX-99.1 14366
8 ex99-2.htm EX-99.2 13976
9 ex99-1_001.jpg GRAPHIC 2862
10 ex99-2_001.jpg GRAPHIC 2862
  Complete submission text file 0001493152-24-005157.txt   1252658

Data Files

Seq Description Document Type Size
11 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cing-20240202.xsd EX-101.SCH 3781
12 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cing-20240202_def.xml EX-101.DEF 26635
13 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cing-20240202_lab.xml EX-101.LAB 36718
14 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cing-20240202_pre.xml EX-101.PRE 25259
25 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5636
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 24601371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)